PRESS RELEASE published on 08/14/2025 at 07:01, 1 year 2 months ago Amélioration du résultat opérationnel et du bénéfice semestriel pour la Banque Cler Au premier semestre 2025, la Banque Cler affiche des résultats en hausse: +17,3% pour le résultat opérationnel et +1,1% pour le bénéfice semestriel. Investissements dans l'expérience clientèle et le renforcement de la structure financière Croissance Investissements Banque Cler Résultat Semestriel Management Financier
PRESS RELEASE published on 08/14/2025 at 07:00, 1 year 2 months ago Swiss Re reports a net income of USD 2.6 billion for the first half of 2025 Swiss Re reports a net income of USD 2.6 billion for the first half of 2025, driven by strong underwriting margins and increased investment result across all Business Units Financial Performance Net Income Swiss Re Investment Result Underwriting Margins
PRESS RELEASE published on 08/14/2025 at 07:00, 1 year 2 months ago 3U HOLDING AG: sound development of business in the first half of 2025 despite a challenging environment 3U HOLDING AG reports sound business development in the first half of 2025 despite challenges, affirms outlook. Strategic realignment in HVAC segment and extended Bitcoin investment Business Development 3U HOLDING AG Strategic Realignment Bitcoin Investment First Half 2025
PRESS RELEASE published on 08/14/2025 at 07:00, 1 year 2 months ago CEWE confirms annual forecast with strong Q2 turnover CEWE Stiftung & Co. KGaA confirms annual forecast with strong Q2 turnover, Group turnover up +3.1%. EBIT at EUR -4.0 million in Q2. CEWE honored with 'Best Managed Companies' award Annual Forecast CEWE Stiftung Commercial Online-Print Q2 Turnover Photofinishing Business
PRESS RELEASE published on 08/14/2025 at 07:00, 1 year 2 months ago Relief Therapeutics Publishes 2025 Half-Year Report Relief Therapeutics published its 2025 half-year report, highlighting progress in pipeline candidates for rare diseases and financial status. Corporate update includes advances in wound care and liquid formulation for phenylketonuria Financial Status Relief Therapeutics Rare Diseases 2025 Half-Year Report Pipeline Candidates
PRESS RELEASE published on 08/14/2025 at 07:00, 1 year 2 months ago Wacker Neuson Group publishes Half-year Report and confirms the guidance for the financial year 2025 Wacker Neuson Group publishes Half-year Report for H1/2025, confirming guidance for 2025. Revenue at EUR 1,074.9 million, EBIT margin at 5.2%. Free cash flow positive at EUR 67.7 million Revenue Half-year Report EBIT Margin Wacker Neuson Group Financial Year 2025
PRESS RELEASE published on 08/14/2025 at 07:00, 1 year 2 months ago Brockhaus Technologies AG: Revenue rises in H1 2025 by +2.6% to €112 million with adjusted EBITDA of €25 million – 2025 outlook confirmed Brockhaus Technologies AG reports +2.6% revenue growth in H1 2025 to €112 million, adjusted EBITDA at €25 million, confirmed outlook for 2025 Adjusted EBITDA Revenue Growth Brockhaus Technologies AG 2025 Outlook H1 2025
PRESS RELEASE published on 08/14/2025 at 07:00, 1 year 2 months ago Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4 Sanofi obtient la désignation de médicament orphelin pour le rilzabrutinib dans l'UE contre la maladie liée aux IgG4. Étude de phase 2 positive présentée à l'EULAR 2025 États-Unis Sanofi Médicament Orphelin Rilzabrutinib Maladie IgG4
PRESS RELEASE published on 08/14/2025 at 07:00, 1 year 2 months ago Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Sanofi’s rilzabrutinib granted orphan designation in EU for IgG4-related disease. Positive Phase 2 results presented at EULAR 2025 Congress showcasing efficacy and safety profile Sanofi Rilzabrutinib Orphan Designation IgG4-related Disease EULAR 2025
PRESS RELEASE published on 08/14/2025 at 06:59, 1 year 2 months ago grenke AG: First half-year 2025 on track grenke AG reports on track first half-year 2025 with earnings of EUR 26.2 million, improved cost-income ratio, and acquisition progress Acquisition Earnings GRENKE AG Cost-income Ratio First Half-year 2025
Published on 11/10/2026 at 02:45, 3 hours 59 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 7 hours 34 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/09/2026 at 23:00, 7 hours 44 minutes ago LNG Energy Group Announces Issuance of Third Partial Revocation Order and Proposed Shares-for-Debt Settlement
Published on 11/09/2026 at 22:32, 8 hours 12 minutes ago Announces Extension for Closing of Private Placement of Convertible Promissory Notes
Published on 11/09/2026 at 22:15, 8 hours 29 minutes ago Goldcliff Announces Closing of the Second and Final Tranche of its "LIFE" Offering and Completion of Drilling at Kettle Valley
Published on 11/10/2026 at 06:00, 44 minutes ago Ad hoc announcement pursuant to Art. 53 LR 10 November 2026
Published on 11/10/2026 at 04:55, 1 hour 49 minutes ago The 19th Europe-China Business and Technology Cooperation Fair boosts business cooperation
Published on 11/10/2026 at 01:20, 5 hours 24 minutes ago US defence customer steps up orders and first graphene oxide orders secured
Published on 11/09/2026 at 18:30, 12 hours 14 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 18:30, 12 hours 14 minutes ago Air Liquide a réalisé avec succès une émission obligataire multi-tranches de 390 millions de CHF
Published on 11/09/2026 at 17:45, 12 hours 59 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 11/09/2026 at 17:45, 12 hours 59 minutes ago Déclaration des droits de vote à fin octobre 2026